Results
A total of 173 patients underwent arch reconstruction: 32 (18%) had single-ventricular defect and the remaining 141 (82%) had double-ventricular physiology. While 60 (35%) patients were operated on using ACP-CA, the remaining 113 (65%) patients were operated on using BHAS. Thirty-three (19%) patients underwent surgery for isolated transverse aortic arch (TAA) hypoplasia and the procedure was performed in this group without inducing CA. Arch reconstruction and VSD closure were performed in 63 (36%) patients. Seventy-seven (45%) patients underwent surgery for either arch reconstruction as well as non-VSD pathologies (Table 1).